Search results
Results From The WOW.Com Content Network
Anti-Fy a is a common antibody while anti-Fy b is approximately 20 times less common., [106] [107] They are reactive at body temperature and are therefore clinically significant, although they do not typically bind complement. Antibodies are acquired through exposure (pregnancy or history of blood transfusion) and subsequent alloimmunization.
In the antibody screening procedure, an individual's plasma is added to a panel of two or three sets of red blood cells which have been chosen to express most clinically significant blood group antigens. Only group O cells are used in antibody screening, as otherwise the cells would react with the naturally occurring ABO blood group antibodies.
The term human blood group systems is defined by the International Society of Blood Transfusion (ISBT) as systems in the human species where cell-surface antigens—in particular, those on blood cells—are "controlled at a single gene locus or by two or more very closely linked homologous genes with little or no observable recombination between them", [1] and include the common ABO and Rh ...
Antibodies to blood group system antigens and their characteristics must be identified when such antibodies are detected in a potential recipient's serum or plasma. [9] The specificity of the antibody aids the medical laboratory scientist in determining if the antibody is clinically significant. Antibody identification is a very laborious ...
A clinically significant antibody is an antibody that is capable of causing in vitro hemolysis or a decreased survival of transfused donor red blood cells. [7] Antibodies to high frequency antigens can be assessed for clinical significance using the monocyte monolayer assay.
Anti-M and anti-N are generally clinically insignificant. Anti-S, anti-s and anti-U antibodies are acquired following exposure (via pregnancy or past transfusion with blood products) and are warm-reacting IgG-class antibodies. [7] Anti-S, anti-s and anti-U are usually clinically significant.
The severity and prognosis of acute hemolytic transfusion depends on the rate of blood administration and the total volume of the transfusion. The levels of anti-A and anti-B antibodies in the recipients blood may also predict the prognosis, with higher levels of antibodies thought to portend a more severe course. [6]
The same study also identified 18 rare alleles, which generally have a weaker glycosylation activity. People with weak alleles of A can sometimes express anti-A antibodies, though these are usually not clinically significant as they do not stably interact with the antigen at body temperature. [41]